Photoinactivation of viruses

Photochemical and Photobiological Sciences

Volumn 3, Issue 5, 2004, Pages 406-411

  Wainwright, Mark ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4' AMINOMETHYL 4,5',8 TRIMETHYLPSORALEN; AMINOLEVULINIC ACID; AMOTOSALEN; BLUEFLEX; FUROCHROMONE DERIVATIVE; HEMATOPORPHYRIN DERIVATIVE; HYDROXYUREA; IDOXURIDINE; METHYLENE BLUE; NEUTRAL RED; NUCLEIC ACID; PATHINACT MB; PHENOTHIAZINE DERIVATIVE; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PHTHALOCYANINE DERIVATIVE; PORPHYRIN; PROFLAVINE; PSORALEN; PSORALEN DERIVATIVE; RIBOFLAVIN; TRIOXYSALEN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENZYME;

ANTIVIRAL ACTIVITY; ARTICLE; BLOOD COMPONENT; BLOOD TRANSFUSION; BOWEN DISEASE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTACT DERMATITIS; DISINFECTION; DRUG DESIGN; DRUG STRUCTURE; DRUG TARGETING; DRUG WITHDRAWAL; GENITAL HERPES; HERPES SIMPLEX KERATITIS; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN; IN VIVO STUDY; LARYNX PAPILLOMATOSIS; LEUKOPENIA; MOLLUSCIPOXVIRUS; MOLLUSCUM CONTAGIOSUM; PAIN; PAPILLOMA VIRUS; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; SKIN DISEASE; VERRUCA VULGARIS; VIRUS INACTIVATION; VIRUS INFECTION;

HERPES;

EID: 3042818896     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b311903n     Document Type: Article

References (52)

1. M. Germain M. Goldman Blood donor selection and screening: strategies to reduce recipient risk Am. J. Ther. 2002 9 406-410.
2. E. Ben-Hur B. Horowitz Advances in photochemical approaches for blood sterilization Photochem. Photobiol. 1995 62 383-388.
3. C. Wallis J. L. Melnick Photodynamic inactivation of animal viruses: a review Photochem. Photobiol. 1965 4 159-170.
4. D. Crowther J. L. Melnick The incorporation of neutral red and acridine orange into developing poliovirus particles making them photosensitive Virology 1961 14 11-21.
5. L. Corash Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates Vox Sang. 2000 78 205-210.
6. Z. Smetana E. Mendelson J. Manor J. E. van Lier E. Ben-Hur S. Salzberg Z. Malik Photodynamic inactivation of herpes viruses with phthalocyanine derivatives J. Photochem. Photobiol., B 1994 22 37-43.
7. E. Ben-Hur M. M. Zuk M. E. Kenney N. L. Oleinick J. Mulvihill B. Horowitz Action spectra (660-700 nm) for virus inactivation and red cell damage photosensitised by the silicon phthalocyanine Pc4 Lasers Med. Sci. 1996 11 221-225.
8. C. M. Allen J. M. Weber J. E. Van Lier Sulfophthalocyanines for photodynamic inactivation of viruses in blood products: effect of structural modifications Photochem. Photobiol. 1995 62 184-189.
9. S. Rywkin E. Ben-Hur Z. Malik A. M. Prince Y.-S. Li M. E. Kenney N. O. Oleinick B. Horowitz New phthalocyanines for photodynamic virus inactivation in red blood cell concentrates Photochem. Photobiol. 1994 60 165-170.
10. C. Moore C. Wallis J. L. Melnick M. D. Kuns Photodynamic treatment of herpes keratitis Infect. Immun. 1972 5 169-171.
11. C. D. Lytle L. D. Hester Photodynamic treatment of herpes simplex virus infection in vitro Photochem. Photobiol. 1976 24 443-448.
12. R. L. Goldenberg K. Nelson Dermatitis from neutral red therapy of herpes genitalis Obstet. Gynecol. 1975 46 359-360.
13. L. S. Kucera J. P. Gusdon I. Edwards G. Herbst Oncogenic transformation of rat embryo fibroblasts with photoinactivated herpes simplex virus: rapid in vitro cloning of transformed cells J. Gen. Virol. 1977 35 473-485.
14. G. S. L. Yen E. H. Simon Photosensitization of herpes simplex virus Type 1 with neutral red J. Gen. Virol. 1978 41 273-281.
15. W. T. Speck R. M. Santella S. Brem H. S. Rosencrantz Alteration of human cellular DNA by neutral red in the presence of visible light Mutat. Res. 1979 66 95-98.
16. C. D. Lytle P. G. Carney R. P. Felten H. F. Bushar R. C. Straight Inactivation and mutagenesis of herpes virus by photodynamic treatment with therapeutic dyes Photochem. Photobiol. 1989 50 367-371.
17. W. L. Morison Anti-viral treatment of warts Br. J. Dermatol. 1975 92 97-99.
18. M. K. Fehr C. F. Chapman T. Krasieva B. J. Tromberg J. L. McCullough M. W. Berns Y. Tadir Selective photosensitiser distribution in vulvar condylomata acuminatum after topical application of 5-aminolevulinic acid Am. J. Obstet. Gynecol. 1996 174 951-957.
19. R. G. J. Frank J. D. Bos F. W. van der Meulen H. J. C. M. Stevenborg Photodynamic therapy for condylomata acuminate with local application of 5-aminolevulinic acid Genitourin. Med. 1996 72 70-71.
20. D. C. Shackley C. Briggs A. Gilhooley C. Whitehurst K. J. O’Flynn C. D. Betts J. V. Moore N. W. Clarke Photodynamic therapy for superficial bladder cancer under local anaesthetic Br. J. Urol. Int. 2002 89 665-70.
21. A. L. Abramson L. S. Hirschfield M. J. Shikowitz N. X. Barrezueta The pathologic effects of photodynamic therapy on the larynx. Experimental study Arch. Otolaryngol. Head Neck Surg. 1988 114 33-39.
22. V. Mullooly A. L. Abramson M. J. Shikowitz Dihematoporphyrin ether-induced photosensitivity in laryngeal papilloma patients Lasers Surg. Med. 1990 10 349-356.
23. N. M. Bauman R. J. H. Smith Recurrent respiratory papillomatosis Pediatr. Clin. North Am. 1996 43 1385-1401.
24. A. L. Shikowitz K. Freeman B. M. Steinberg M. Nouri Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results Laryngoscope 1998 108 962-967.
25. Z. Smetana Z. Malik A. Orenstein E. Mendelson E. Ben Hur Treatment of viral infections with 5-aminolevulinic acid and light Lasers Surg. Med. 1997 21 351-358.
26. J. Krutmann Phototherapy for atopic dermatitis Clin. Exp. Dermatol. 2000 25 552-558.
27. G. D. Cimino H. B. Gamper S. T. Isaacs J. E. Hearst Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry and biochemistry Annu. Rev. Biochem. 1985 54 1151-1193.
28. P. D. Wood A. Mnyusiwalla L. Chen J. L. Johnston Reactions of psoralen radical cations with biological substrates Photochem. Photobiol. 2000 72 155-162.
29. L. Corash Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates Vox Sang. 2000 78 205-210.
30. D. Pamphilon Viral inactivation of fresh frozen plasma Br. J. Haematol. 2000 109 680-693.
31. C. M. Allen W. M. Sharman J. E. Van Lier Current status of phthalocyanines in the photodynamic therapy of cancer J. Porphyrins Phthalocyanines 2001 5 161-169.
32. M. Wainwright Photodynamic antimicrobial chemotherapy (PACT) J. Antimicrob. Chemother. 1998 42 13-28.
33. M. Wainwright The use of methylene blue derivatives in blood product disinfection Int. J. Antimicrob. Agents 2000 16 381-394.
34. R. Bonnett Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy Chem. Soc. Rev. 1995 24 19-33.
35. E. Ben Hur B. Horowitz Virus inactivation in blood AIDS 1996 10 1183-1190.
36. E. Ben Hur A. CE. Moor H. Margolis-Nunno P. Gottlieb M. M. Zuk S. Lustigman B. Horowitz A. Brand J. Van Steveninck T. M. Dubbelman The photodecontamination of cellular blood components: mechanisms and use of photosensitization in transfusion medicine Transfus. Med. Rev. 1996 10 15-22.
37. C. M. Allen J. M. Weber J. E. van Lier Sulfophthalocyanines for photodynamic inactivation of viruses in blood products - effects of structural modifications Photochem. Photobiol. 1995 62 184-189.
38. M. Wainwright D. A. Phoenix L. Rice S. M. Burrow J. J. Waring Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation J. Photochem. Photobiol., B 1997 40 233-239.
39. L. Strekowski D.-F. Hou R. L. Wydra R. F. Schinazi A synthetic route to 3-(dialkylamino)phenothiazin-5-ium salts and 3,7-disubstituted derivatives containing two different amino groups J. Heterocycl. Chem. 1993 30 1693-1695.
40. M. Wainwright D. A. Phoenix S. L. Laycock D. RA. Wareing P. A. Wright Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus FEMS Microbiol. Lett. 1998 160 177-181.
41. E. W. Schultz A. P. Krueger Inactivation of Staphylococcus bacteriophage by methylene blue Proc. Soc. Exp. Biol. Med. 1928 26 100-101.
42. E. M. Tuite J. M. Kelly Photochemical interactions of methylene blue and analogues with DNA and other biological substrates J. Photochem. Photobiol., B 1993 21 103-124.
43. B. Bachmann J. Knüver-Hopf B. Lambrecht H. Mohr Target structures for HIV-1 inactivation by methylene blue J. Med. Virol. 1995 47 172-178.
44. H. Morrison T. Mohammad R. Kurukulasuriya Photobiological properties of methylene violet Photochem. Photobiol. 1997 66 245-252.
45. A. Klein-Struckmeier H. Mohr Photodynamic virus inactivation of thrombocyte concentrates by phenothiazine dyes Transfusionsmedizin 1997 34 43-47.
46. H. Mohr B. Lambrecht A. Selz Photodynamic virus inactivation of blood components Immunol. Invest. 1995 24 73-85.
47. A. Skripchenko D. Robinette S. J. Wagner Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions Photochem. Photobiol. 1997 65 451-455.
48. M. A. Houghtaling R. Perera K. E. Owen S. Wagner R. J. Kuhn H. Morrison Photobiological properties of positively charged methylene violet analogs Photochem. Photobiol. 2000 71 20-28.
49. S. J. Wagner A. Skripchenko D. Robinette D. A. Mallory L. Cincotta Factors affecting virus photoinactivation by a series of phenothiazine dyes Photochem. Photobiol. 1998 67 343-349.
50. A. A. Skripchenko S. J. Wagner Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: comparison of dimethylmethylene blue and MB Transfusion (Bethesda, Md.) 2000 40 968-975.
51. T. Mohammed H. Morrison Photonuclease activity of Taylor’s blue Bioorg. Med. Chem. Lett. 1999 9 2249-2254.
52. R. P. Goodrich The use of riboflavin for the inactivation of pathogens in blood products Vox Sang. 2000 78 211-215.